Athletic Organizations
Blood-based biomarker monitoring that transforms concussion management from subjective symptom assessment to standardized, defensible evidence — from baseline through return-to-play.
The Landscape
NFL litigation settlements have exceeded $1.18 billion with no monetary cap. NCAA, youth sports, and professional leagues face increasing pressure to demonstrate objective concussion management protocols. Subjective symptom checklists are no longer sufficient.
$1.18B+
NFL Settlement Payments
No Cap
On Future NFL Claims
3.8M
Sports Concussions Per Year (US)
Monitoring Model
Pre-season biomarker assessment establishing each athlete's individual reference range for GFAP, NfL, and related markers.
Post-concussion biomarker draw providing objective measurement of acute injury severity — independent of symptom reporting.
Serial biomarker monitoring tracking recovery trajectory. Objective data to inform return-to-play timing and clearance decisions.
Action Protocols
Green Level
Biomarker levels within baseline range. Standard follow-up schedule.
Yellow Level
Elevated biomarker levels indicating ongoing neural stress. Restrict activity and retest at defined intervals.
Red Level
Significantly elevated biomarkers. Immediate clinical referral and activity restriction until levels normalize.
Organizational Impact
Documented, objective concussion management protocols reduce liability for leagues, schools, and organizations.
Replace subjective symptom checklists with measurable biomarker data for return-to-play and retirement decisions.
Transparent, science-based protocols demonstrate genuine commitment to player health and long-term welfare.
Multi-year biomarker profiles for each athlete — enabling trend detection and early intervention before symptoms escalate.
Deploy objective biomarker monitoring for your athletes. We work with leagues, teams, schools, and governing bodies to implement standardized concussion protocols.
© 2026 New World Partners Healthcare. All rights reserved.
